Mineralys Therapeutics (MLYS) Times Interest Earned (2022 - 2025)
Mineralys Therapeutics (MLYS) reported Times Interest Earned of -$0.26 for Q4 2025, up 59.61% on a YoY basis from -$0.16 in Q4 2024, and up 59.61% sequentially from -$0.65 in Q4 2024.
Mineralys Therapeutics (MLYS) Times Interest Earned (2022 - 2025) Analysis & Trends
Mineralys Therapeutics (MLYS) has 4 years of Times Interest Earned data on file, last reported at -$0.26 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 59.61% year-over-year to -$0.26; the trailing twelve-month figure through Dec 2025 stood at -$1.17 (up 51.56% YoY), and the FY2025 full-year result was -$1.17, up 51.56% from the prior year.
- Times Interest Earned improved to -$0.26 in Q4 2025, from -$0.65 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.26 in Q4 2025 to a low of -$32.33 in Q4 2023.
- A 4-year average of -$8.47 and a median of -$0.65 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned plunged 4927.61% in 2023 and jumped 98.0% in 2024, its largest moves.
- Tracing MLYS's Times Interest Earned over 4 years: stood at -$0.64 in 2022, then sank by 4927.61% to -$32.33 in 2023, then jumped by 98.0% to -$0.65 in 2024, then soared by 59.61% to -$0.26 in 2025.
- Business Quant data shows MLYS's Times Interest Earned at -$0.26 in Q4 2025, -$0.65 in Q4 2024, and -$32.33 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mineralys Therapeutics | 2.24 Bn | 2.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.65 |
| Dec 31, 2023 | -32.33 |
| Dec 31, 2022 | -0.64 |